SEPTInvestingStart Free

BDRX 6-K: SEC filing

Filed with the SEC on · accession 0001171843-26-007261

BDRX filed a 6-K (foreign company report) with the SEC on Nov 9, 2026. Biodexa Pharmaceuticals PLC furnished a Form 6-K with a press release dated November 9, 2026. The stock moved -2.8% by the first close after the filing.

Summary of the filing

Biodexa Pharmaceuticals PLC furnished a Form 6-K with a press release dated November 9, 2026. The filing itself contains only the cover page and signature; the substantive content is in Exhibit 99.1, which was not included in the provided text.

For details, click here →How to read a 6-K →

Key details

RegistrantBiodexa Pharmaceuticals PLC
Chief executive officer, chief financial officerStephen Stamp

How BDRX stock reacted

Close before

$2.47

Nov 6, 2026

First close after

-2.81%

$2.40

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for BDRX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for BDRX?

Click here

Frequently asked questions

What did BDRX file with the SEC on Nov 9, 2026?

BDRX filed a 6-K (SEC filing). Biodexa Pharmaceuticals PLC furnished a Form 6-K with a press release dated November 9, 2026. The filing itself contains only the cover page and signature; the substantive content is in Exhibit 99.1, which was not included in the provided text.

How do I read a 6-K?

How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.

How did BDRX stock react to this filing?

BDRX closed at $2.47 before the filing and $2.40 on Nov 9, 2026 (-2.81%).

Other BDRX SEC filings

Get alerts when BDRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
BDRX overviewBDRX analysisBDRX newsLatest SEC filings